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The eccrine gland is one of the major cutaneous appen-
dages and secretes sweat. Its principal function is ther-
moregulation during exposure to a hot environment or
physical exercise. In addition to this function, we show
that LL-37, a member of cathelicidin family of anti-
microbial peptides, is expressed in sweat. LL-37 protein
and mRNAwas seen in the eccrine structures of normal
human skin by immunohistochemistry and in situ hy-
bridization. LL-37 was localized to both the eccrine
gland and sweat ductal epithelial cells, whereas dermci-
din, a previously described natural antibiotic in sweat,
was expressed only in the gland itself. The anti-micro-
bial activity of LL-37 and dermcidin against various
bacteria in the sweat ionic environment was demon-
strated by solution colony forming assay using synthetic
peptides, and in sweat obtained from normal volun-
teers. These results indicate that cathelicidin is secreted
in human sweat, has potent anti-microbial activity
against both gram-positive and gram-negative bacteria,
and can, after processing from the preproform, provide
a barrier for protection against infection. Thus, sweat
represents a unique mode of delivery for potent innate
immune e¡ector molecules in the absence of in£amma-
tion. Key words: anti-microbial peptide/cathelicidin/eccrine
gland/LL-37/sweat. J Invest Dermatol 119:1090 ^1095, 2002
I
n mammalian skin, two major classes of anti-microbial
peptides have been identi¢ed: cathelicidins (Zanetti et al,
1995; Gallo et al, 1997; Nizet et al, 2001) and b-defensins
(Ali et al, 2001; Harder et al, 1997; Stolzenberg et al, 1997).
The sole cathelicidin in humans is LL-37 (Agerberth et al,
1995; Frohm et al, 1997), and it is expressed in leukocytes and in
a variety of epithelial surfaces. Cathelicidins and b-defensins have
distinct and overlapping anti-microbial activity (Bals, 2000; Na-
gaoka et al, 2000). The activity of these peptides has been pro-
posed to provide innate defense against a variety of potential
microbial pathogens, and in the case of cathelicidins has been
shown to be essential for skin defense against group A Streptococ-
cus (GAS) (Nizet et al, 2001).
Cathelicidins are a widely expressed family of mammalian
anti-microbial peptides and like many such molecules are synthe-
sized as a preproprotein (Zanetti et al, 1995). This preproprotein
consists of a highly conserved signal sequence and cathelin do-
main but have substantial heterogeneity between species in the
C-terminal domain encoding the mature active peptide. The
anti-microbial activity of cathelicidins is only activated following
proteolytic processing of the active C-terminal peptide from the
cathelin domain of the preproprotein. As originally isolated from
neutrophils granules, the human cathelicidin C-terminal peptide
is a 37 amino acid cationic peptide after cleavage (Gudmundsson
and Agerberth, 1999; Agerberth et al, 2000). LL-37 was also de-
tected directly in human skin keratinocytes, but only where in-
£ammation was present, suggesting this class of anti-microbial
peptides functions primarily in response to injury rather than
in modulating the surface colonization of the skin (Frohm et al,
1997).
The eccrine sweat gland is one of the major cutaneous appen-
dages, and it is a secretory as well as an excretory organ (Sato et al,
1989). The sole function of sweat has been considered to be ther-
moregulation during exposure to a hot environment or during
physical exercise. Recently, a novel anti-microbial peptide ‘‘derm-
cidin’’ was found in the human sweat gland, and showed sweat
may have an additional important role against various bacteria
(Schittek et al, 2001). Though anti-microbial peptides that have
been reported are cationic peptides, this novel peptide is an anio-
nic peptide whose mechanism of action remains unknown.
In this investigation we evaluated expression of cathelicidins in
sweat and the sweat gland, and show sweat has abundant consti-
tutive production of this broad-spectrum and potent natural anti-
biotic. These data provide additional support to the hypothesis
that sweat can play an important part in establishing a skin de-
fense barrier against microbes and should be considered as an
integral part of the innate immune system.
MATERIALS ANDMETHODS
Tissue sampling Normal axillary skins from three healthy adult
volunteers were sampled using a 6 mm punch biopsy. Sample acquisition
was approved by the Committee on Investigations Involving Human
Subjects of the University of California, San Diego. Tissue was
immediately embedded in OCT compound using liquid nitrogen after
biopsy and kept it at ^801C. For immunohistochemistry, fresh frozen
sections were cut at 8 mm, and stored at ^801C until use. For in situ
hybridization, fresh frozen section were cut at 8 mm, then ¢xed with 4%
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paraformaldehyde for 10 min at room temperature, and immersed in 0.1%
active diethyl pyrocarbonate in phosphate-bu¡ered saline (PBS: 137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4.H2O, 1.4 mM KH2PO4) at 41C
overnight before processing.
Human sweat collection For western blot analysis, human sweat was
collected from three healthy volunteers. 2 ml of the crude sweat was
centrifuged at 15,000 r.p.m. (50,000 g) for 10 min, then supernatant
collected. After repeating once, 1 ml of sample was concentrated by
lyophilization, then resuspended in 50 ml of twice glass distilled water,
and the rest of sample was stocked as crude sweat. All samples were stored
at ^201C until use. Total protein concentration of the collected sweat was
evaluated by BCA assay (protein assay reagent, Pierce, Rockford, IL)
according to the manufacturer’s instruction.
Antibodies for LL-37 and dermcidin Rabbit anti-LL-37 polyclonal
antibody was kindly provided from Dr Birgitta Agerberth (Microbiology
and Tumor Biology Center, Stockholm, Sweden) (Gudmundsson et al,
1996; Frohm et al, 1997). Rabbit anti-dermcidin polyclonal antibody was
prepared as previously described (Schittek et al, 2001).
Chicken polyclonal antibodies were derived against cathelin domain
(CATH) peptides by Aves Labs (Tigard, OR). Peptide amino acid
sequences used for immunization were CZNLYRLLDLDPRPTMD for
CATH. Brie£y, hens were injected with a KLH conjugated peptides,
immune eggs collected from these hens, and the IgY fraction puri¢ed
from yolks. IgY fractions were then passed over a⁄nity columns prepared
with the respective immunizing peptides, the columns washed, and
antibody eluted. The stock concentration of the chicken anti-cathelin
antibody was 1.62 mg per ml.
Synthetic peptides for LL-37 and dermcidin Synthetic LL-37,
dermcidin (DCD), and DCD-derived (DCD-1L) peptides were prepared
by Synpep Corporation (Dublin, OR). Peptide amino acid sequences
were LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, SSL-
LEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSV,
and SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVK-
DVLDSVL for LL-37, DCD, and DCD-1L, respectively. The synthetic
peptides were puri¢ed through a HPLC column and identity con¢rmed
by mass spectrometry.
Western blot analysis of sweat Lyophilized sweat samples (10 ml) were
separated by 16.5% Tris^tricine/peptide gel (BIO-RAD, Hercules, CA),
and then transferred on to a nitrocellulose membrane (OSMONICS,
Westborough, MA). For positive control, 5 pmol LL-37 synthetic peptide
was applied. The membrane was treated with blocking solution [0.1%
TTBS: 5% nonfat milk in 0.1% Tween 20/Tris-bu¡ered saline (TBS:
150 mM NaCl, 10 mM Tris Base, pH 7.4)] for 60 min at room temperature,
and then rabbit anti-LL37 polyclonal antibody (1 : 5000 in blocking
solution) was incubated with the membrane overnight at 41C. After
washing the membrane three times with 0.1% TTBS, horseradish
peroxidase labeled goat anti-rabbit polyclonal antibody (1 : 5000 in the
blocking solution) was incubated with the membrane for 60 min, room
temperature. After washing the membrane with 0.1% TTBS, the
membrane was immersed in ECL solution (Western Lightning
Chemiluminescence Reagents Plus, New Lifescience Products, Boston,
MA) for 60 s then exposed to X-ray ¢lm (Kodak).
For further con¢rmation of the identity of the band detected by western
blot, the ¢lter was stripped of antibody (62.5 mM Tris^HCl (pH 6.8), 2%
sodium dodecyl sulfate, 100 mM b-mercaptoethanol) at 501C for 30 min,
then reacted with a chicken anti-cathelin antibody (1 : 10000)
and horseradish peroxidase anti-chicken IgY goat antibody (1 : 10000,
Aves Labs, OR). The ¢lter was stripped of antibody again, then reacted
with a rabbit anti-dermcidin antibody (1 : 6000) and goat horse-
radish peroxidase anti-rabbit IgG antibody as described above.
Measurement of LL-37 concentration in sweat To estimate the
concentration of LL-37, quantitative dot-blot and western blot analysis
was performed. Ten microliters of crude sweat sample were compared
with a standard curve of various concentrations of synthetic peptide
applied on to nitrocellulose ¢lter. After blotting, LL-37 on the
nitrocellulose ¢lter was detected as described above.
Immunohistochemistry For detection of LL-37 and dermcidin
peptides, rabbit anti-LL-37 and anti-dermcidin polyclonal antibodies were
used for immunostaining. Tissue sections were immersed in PBS after 4%
paraformaldehyde ¢xation for 5 min, and endogenous peroxidase activity
blocked with a 30 min incubation in 0.3% H2O2 in methanol. After
washing with PBS, sections were blocked with 2% goat serum in PBS for
30 min, then incubated with primary antibody, rabbit anti-LL-37 (1 : 1000)
or rabbit anti-dermcidin (1 : 3000) in PBS, 3% bovine serum albumin for
60 min. Sections were washed in PBS and the signals detected with
Vectorstain ABC Elite Rabbit kit (Vector Laboratories, Burlingame, CA)
following the manufacturer’s instructions. As a negative control, the
polyclonal antibody was replaced by normal rabbit preimmune IgG
diluted with PBS containing 3% BSA at the same protein concentration
as that used for the primary antibody. Finally, sections were incubated in
0.02% diaminobenzidine with 0.05% H2O2 in PBS for 1 min and
counterstained with Mayer’s hematoxylin for 30 s. All procedures were
carried out at room temperature.
In situ hybridization For preparing in situ probes, PCR products of the
cathelin domain sequence (CDS, 236 bp) and LL-37 mature form sequence
(LL-37mfs, 137 bp) were ampli¢ed, respectively. This product was
sequenced to con¢rm identity, then inserted in the PCR II-TOPO vector
(TOPO TA Cloning version M; Invitrogen, Carlsbad, CA). Plasmid DNA
was subsequently puri¢ed using a DNA Extraction Maxi Kit (Qiagen,
Valencia, CA) and linearized with restriction enzymes (HindIII and XbaI
for CDS, HindIII and XhoI for LL-37mfs) for anti-sense and sense RNA
probe, respectively. Digoxigenin-labeled riboprobes were prepared on
linearized plasmid using the digoxigenin RNA labeling kit (SP6/T7,
Roche Molecular Biochemicals, Mannheim, Germany) following the
instructions provided. Two microliters of the plasmid containing cDNA
for CDS and LL-37mfs were blotted on nitrocellulose ¢lters
(OSMONICS,Westborough, MA) and ultraviolet cross-linked to con¢rm
the speci¢city of the labeled probes, respectively.
After washing with PBS at room temperature for 10 min, sections were
treated with a 1 M triethanolamine solution (pH 8.0) containing 0.25%
acetic anhydride for 15 min at 371C, washed with PBS at least three
times, then treated with 100% ethanol for 5 min, and then dried.
Prehybridization was performed with 50% formamide in  2 sodium
saline citrate (3 M sodium chloride, 0.03 M sodium citrate) for 30 min at
451C. After removing excess solution, sections were hybridized for 16 h at
451C with sense or anti-sense digoxigenin-labeled cRNA probes (1 mg per
ml) in hybridization solution (1 mg per ml yeast tRNA, 20 mM Tris^HCl
bu¡er (pH 8.0), 2.5 mM ethylenediamine tetraacetic acid, 1Denhardt’s
solution, 0.3 M NaCl, 50% deionized formamide, 50% dextran sulfate).
Stringent washing was performed for 60 min at 451C with 50%
formamide in  2 sodium saline citrate, and for 10 min at 371C with  2
sodium saline citrate. RNase treatment was carried with 40 mg per ml of
RNase-A (Roche Molecular Biochemicals) for 30 min at 371C. After
washing with the  2 sodium saline citrate for 30 min at 371C, sections
were reacted with anti-digoxigenin alkaline phosphate Fab fragment
antibody (1 : 500, in PBS; Roche Molecular Biochemicals) for 5 h at
room temperature. Alkaline phosphate was visualized by incubation with
5-bromo-4-chloro-3-indolyl phosphate (X-phosphate) and nitroblue
tetrazolium with addition of levamisole solution (DAKO, Carpinteria,
CA) overnight at room temperature. Methyl green stain was used for the
nuclear counter stain. RNA preservation in tissues was con¢rmed by
similar hybridizations using a keratin 14 anti-sense probe (insert 175 bp).
Anti-microbial assay To evaluate the anti-microbial activity of LL-37,
dermcidin, and total sweat, colony-forming unit assay was performed
with Staphylococcus aureus (isolated from clinical sample), GAS (NZ131),
and enteroinvasive Escherichia coli O29 as described (Porter et al, 1997).
Before analysis, we determined the concentration of the bacteria in
culture by plating di¡erent bacterial dilutions (at A600, 1.0 corresponded to
3.5109 per ml for S aureus, 2.5108 and GAS, and 3.5108 for E. coli).
Cells were washed twice with 10 mM sodium phosphate bu¡er (20 mM
NaH2PO4.H2O, 20 mM Na2HPO4.7H2O) and diluted to a concentration
of 2106 cells per ml (S. aureus, GAS) or 2105 cells per ml (E. coli) in
sweat bu¡er (40 mM NaCl, 10 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM
Na dihydrogen phosphate, pH 6.5) (Schittek et al, 2001) or phosphate
bu¡er. S. aureus and E. coli were incubated for 4 h at 371C with various
concentrations of LL-37 or dermcidin peptides in 50 ml of bu¡ers using
wells of a 96 well round bottom tissue culture plate (Costar 3799,
Corning inc., NY). GAS was incubated for 1 h due to the poor ability of
GAS to grow in these bu¡ers. After incubation, the cells were diluted from
10 to 105 , and each of 20 ml of those solutions were plated in triplicate
on tryptic soy broth (for S. aureus) and Todd Hewitt broth (for GAS and E.
coli), then the mean number of colonies determined.The number of cfu per
ml was calculated, and the bactericidal activities of the tested regents were
calculated as follows: (cell survival after peptide incubation)/(cell survival
after incubation without peptide) 100, which represented the percentage
of cells that were alive (% live).
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RESULTS
Human cathelicidin LL-37 is expressed in sweat Normal
human sweat was evaluated by western blot with two antibodies
independently derived against distinct domains of the cathelicidin
proprotein: anti-cathelin and anti-LL-37. LL-37 was present
in human sweat (Fig 1a). Three bands were detected with
anti-LL37 at 18, 14 and 5 kDa. A single band was seen with anti-
cathelin, migrating identically to that seen at 18 kDa with anti-
LL-37. This 18 kDa corresponds to the expected size of the full-
length cathelicidin, whereas the 5 kDa band corresponds to the
expected mature anti-microbial peptide. Parallel to exploring
the LL-37 expression, dermcidin protein expression was also
evaluated by western blotting. After detection of LL-37 protein,
the ¢lter was stripped of antibody and dermcidin peptide was
evaluated (Fig 1a). The antibody detected three bands at 20, 14.5,
and 10 kDa.
To evaluate more quantitatively the concentration of
cathelicidin and dermcidin in normal sweat samples, dot-blot
and western blot analysis was performed by comparison with
known amounts of synthetic LL-37 peptide. LL-37 content of
the human sweat was found to vary considerably between
patients, with an average concentration of E1 mM in the crude
sweat collected from normal volunteers (Fig 1b: LL-37). Further-
more, western blot analysis of normal sweat demonstrated that
cathelicidin was processed into active LL-37 and represented
approximately 10% of the total immunoreactive material
(Fig 1c).
In contrast to the variability in LL-37 detected between
individual sweat preparations, the relative amount of dermcidin
was similar in identical patient samples (Fig 1b: DCD). The con-
centration of dermcidin could not be determined as the antigenic
epitope of the dermcidin detecting antibody was directed against
the pro-domain and is not present on the active dermcidin
peptide.
LL-37 protein is expressed in the human eccrine sweat
gland To explore further cathelicidin expression and localiza-
tion, skin biopsies were examined for LL-37 protein expression
by immunohistochemistry. Abundant LL-37 was detected in the
eccrine gland (Fig 2a,c). Staining was di¡usely located in the
cytoplasm of both of the clear and dark cells in the secretory
gland (Fig 2a). Ductal epithelium in dermis also showed pro-
tein expression, and strong staining could be found in the
apical portion in the ductal cell (Fig 2c). Unlike results from
western blots of individual collections of secreted sweat, no
variability was seen between patient expression of LL-37 by
immunohistochemistry.
The localization of dermcidin contrasted with the localization
of LL-37. Dermcidin was seen only in the secretory glands but
not in the ducts (Fig 2b,d). Expression was the strongest on the
surface of dark cells in the eccrine gland proper (Fig 2b).
LL-37 mRNA is expressed in the eccrine sweat gland To
explore expression of cathelicidin mRNA in eccrine appendages,
in situ hybridization was performed. Nonradioactive in situ
Figure1. Human sweat contains LL-37 and dermcidin. Human sweat preparations and synthetic LL-37 peptide evaluated by western blot (a,c) or dot
blot (b). (a) Ten microliters of lyophilized sweat samples and 5 pmol LL-37 synthetic peptide for positive control were applied for sodium dodecyl sulfate^
polyacrylamide gel electrophoresis and western blot. Membrane was probed with rabbit anti-LL-37 (LL-37), stripped and reprobed with chicken antibody
against the cathelin immature domain (CATH). (A) Arrow (18 kDa) corresponds to expected size of full length human cathelicidin. (B) Arrow (14 kDa) is
intermediate size suggesting partial processing of cathelicidin. (C) Arrow corresponds to 5 kDa mature LL-37 anti-microbial peptide. After detection of
cathelicidin with both antibodies, the ¢lter was stripped of antibody again and dermcidin was detected (DERM). This antibody detected three bands at
20, 14.5, and 10 kDa. (b) LL-37 dot blot of individual patient samples compared with known LL-37 standards in duplicate (S-1, S-2). Total protein concen-
tration was 72.3 mg per ml for no. 1, 122.5 mg per ml for no. 2, 361.9 mg per ml for no. 3, respectively. Relative dermcidin detected in patient samples is also
shown (DCD). (c) Quantitative western blotting for sweat sample no. 1 shows LL-37 in 1 mL and 10 mL sweat compared with 1 pmol or 0.5 pmol synthetic
LL-37.
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hybridization with digoxigenin-labeled cRNA anti-sense probes
for the immature cathelin domain (CDS) (Fig 3a) and LL-37
mature peptide (mfs) (Fig 3c) showed that the LL-37 mRNA
was expressed in tissues previously found positive by immuno-
histochemistry. Intense signal was found in the cytoplasm of the
gland cells, around the nucleoli, and mRNA was also found in
the ductal epithelium in dermis by using both CDS and LL-
37mfs probes. No signal was detected with sense probes as
control in every tissue (Fig 3b,d). Relative abundance of LL-37
mRNAwas similar in all samples.
Anti-microbial activities of LL-37 and dermcidin in sweat
bu¡er and phosphate bu¡er To investigate the antibacterial
activity of LL-37 in sweat, bactericidal assays were performed.
S. aureus or E. coli was incubated for 4 h, and GAS was incubated
for 1 h, at 371C in sweat bu¡er (Fig 4a) or phosphate bu¡er
(Fig 4b). LL-37 (8 mM), killed 97% of E. coli and 80% of
S. aureus in sweat bu¡er, and 2 mM of LL-37 killed 79% of E. coli
and 85% of S. aureus in phosphate bu¡er. In sweat bu¡er, 4 mM of
LL-37 killed 68% of GAS and 4 mM of LL-37 killed 66% of GAS
in phosphate bu¡ers after 1 h.
Synthetic dermcidin (DCD) or DCD-1L had no e¡ect on E.
coli, S. aureus, or GAS in either bu¡er at peptide concentrations
under 16 mM, nor could we identify synergistic activity of LL-37
and DCD or DCD-1L. Synthetic DCD was e¡ective in killing
E. coli (100%) and S. aureus (40%) in sweat bu¡er at 80 mM, and
160 mM of DCD killed 66% S. aureus in sweat bu¡er (Fig 4c).
To determine if crude human sweat was anti-microbial,
individual sweat preparations previously evaluated for LL-37 and
dermcidin composition in Fig 1were inoculated with GAS and
bacterial survival measured (Fig 4d). GAS survival varied with
the observed concentration of LL-37. Patient samples 1 and 3,
which had LL-37 in greatest abundance, killed over 95% of the
initial inoculum, whereas in sample 2, which had little detectable
LL-37 but similar amounts of dermcidin, the majority of GAS
survived.
Figure 2. LL-37 protein is expressed in eccrine glands and ductal
epithelium. LL-37 protein is localized in both the eccrine secretory glands
and ducts (a,c). LL-37 protein is di¡usely located in the cytoplasm of the
secretory gland (a), and also located in the ductal epithelium of the ducts
(arrows) (c). Strongest signal could be found in the apical portion in the
ductal cell (c). Dermcidin protein is located in the secretory glands (b) but
not in the ducts (arrows) (d ). Strong expression is found in the lumen of the
gland and dark cells (b). For negative control, preimmune rabbit IgG was
used (e). Hematoxylin and eosin staining was also performed for observa-
tion of sweat gland structure ( f ). Scale bar¼ 40 mm.
Figure 3. LL-37 mRNA is expressed in the eccrine glands and duc-
tal epithelium. LL-37 mRNA is localized by in situ hybridization using
speci¢c anti-sense LL-37 cRNA probes directed against distinct domains
in the immature cathelin portion of the gene (CDS) (a), or the mature pep-
tide domain (LL37mfs) (c). Intense mRNA signal was found in the cyto-
plasm of the gland, around the nucleoli, and in the ductal epithelium using
both CDS and LL-37mfs probes. No signal was detected with both sense
probes as negative control (b,d ). Scale bar¼ 40 mm.
Figure 4. LL-37 synthetic peptide kills E. coli, S. aureus, and GAS in
both sweat and phosphate bu¡er. The anti-microbial activity of LL-37
and dermcidin synthetic peptides was evaluated by solution killing assay. S.
aureus (m), E. coli (’), and GAS () were evaluated in sweat bu¡er (a) and
phosphate bu¡er (b). Synthetic dermcidin (DCD) at high concentrations
was active against E. coli and S. aureus in sweat bu¡er (c).Values are percen-
tage of living bacteria compared with the control (no synthetic peptide).
Data shown are representative of triplicate determinations from three inde-
pendent experiments. Anti-microbial activity of individual crude human
sweat preparations against GAS (d). patient sweat samples correspond to
those shown in Fig 1(b).
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DISCUSSION
Skin is constantly exposed to a variety of microbial pathogens.
Thus, its function as a protective barrier to resist infection is im-
portant. Anti-microbial peptides are essential elements of epithe-
lial defense participating in a variety of immune mechanisms
both direct and indirect (Zaslo¡, 2002). Cathelicidin anti-micro-
bial peptides are constitutively expressed in neutrophils, lung and
gut epithelium, but have only been seen at signi¢cant levels in
skin during in£amed conditions such as wound healing (Frohm
et al, 1997; Gallo et al, 1997; Bals et al, 1998). Simultaneously, anti-
microbial peptides of the defensin family, in particular human b-
defensin 1 (hBD1), 2 (hBD2), and 3 (hBD3), have recently been
described in normal skin (Ali et al, 2001), but are most abundant
in disease conditions such as psoriasis (Harder et al, 2001). In this
investigation we asked if cathelicidins are expressed in signi¢cant
amounts in sweat, thus providing an additional innate anti-mi-
crobial defense system under nonin£ammatory conditions.
Our results show that the human cathelicidin LL-37 is ex-
pressed in sweat, and is present in both mature and immature
forms. A combination of distinct antibodies against di¡erent do-
mains of human cathelicidin was used in this study. The rabbit
anti-LL-37 antibody derived against the C-terminal mature pep-
tide identi¢ed an 18 kDa immature form, a 14 kDa band and the
mature peptide. A chicken antibody derived against the N-term-
inal precursor cathelin domain detected only the expected 18 kDa
form. In all samples evaluated, the majority of soluble immunor-
eactive material was found as this propeptide (Agerberth et al,
1995). This precursor protein blocks the anti-microbial activity
of LL-37 until it is activated by proteinase cleavage to free the
C-terminal active peptide fragment (Zanetti et al, 1990; Shi and
Ganz, 1998). For example, proteinase 3 is responsible for cleavage
of LL-37/hCAP-18 after exocytosis from activated human neutro-
phils (Sorensen et al, 2001). Finding LL-37 as both the inactive
pro-form and active peptide in sweat suggests it can be processed
after secretion, perhaps by one of the several proteases present at
the skin surface (Fraki and Hopsu-Havu, 1976). It is also possible
that either host proteases released after barrier disruption, or mi-
crobial proteases expressed during infection, could serve to cleave
sweat cathelicidin, thus further providing natural antibiotic pro-
tection when needed.
Recently, a novel anti-microbial peptide ‘‘dermcidin’’ was re-
ported as expressed in sweat glands (Schittek et al, 2001). Dermci-
din has a net negative charge of 2 in contrast to anti-microbial
peptides such as cathelicidins and defensins that are highly catio-
nic.This di¡erence suggests the mechanism of bacterial killing by
dermcidin is much di¡erent from cathelicidins. Our results show
that expression of dermcidin and cathelicidin is di¡erent; dermci-
din is secreted from granules in the dark cell, but LL-37 is present
in the epithelium of both gland and duct. In this study, dermcidin
synthetic peptides had poorer activity than synthetic LL-37
against E. coli, GAS, and S. aureus.We speculate that, unlike cathe-
licidins, dermcidin anti-microbial activity depends on structural
conformations or the presence of additional cofactors not yet
identi¢ed. This dependence on unknown cofactors or structure
is suggested by the di¡erences seen in activity between synthetic
peptide and the more potent native peptide previously described
(Schittek et al, 2001). Further work is necessary to understand the
mechanism of action of this unique anti-microbial protein.
Cathelicidins have broad-spectrum activity against gram-posi-
tive and gram-negative bacteria such as S. aureus, Pseudomonas
aeruginosa, and E. coli, as well as against fungi and envelope viruses
(Bals et al, 1998; Johansson et al, 1998; Turner et al, 1998).We have
also shown that LL-37 or the murine cathelicidin CRAMP are
potent inhibitors of GAS, one of the most prevalent and poten-
tially invasive skin pathogens (Dorschner et al, 2001). In this prior
work, as well as the present data on in vitro killing by LL-37 in
sweat bu¡ers, the concentration of LL-37 required for e⁄cient
anti-microbial action generally exceeds 2 mM; however, the con-
centration of mature LL-37 observed here was at least 20-fold less
than what is apparently necessary for anti-microbial activity. A
greatly increased local concentration of LL-37 would be expected
after normal evaporation, and this may enhance the e¡ectiveness
of newly secreted anti-microbial peptides in solution. Crude
sweat collected in this study, however, a¡ected bacterial survival
without concentration, and this activity correlated with the rela-
tive abundance of LL-37 detected in each sample. This observa-
tion may be explained by the presence of anti-microbial
molecules other than cathelicidins or dermcidin. These other mo-
lecules may be primarily responsible for the anti-microbial action
of the crude sweat samples, or may act synergistically with the
cathelicidin and/or dermcidin that has been identi¢ed in sweat
in this study. Precedence for synergistic activity has been ob-
served with combinations of LL-37 and defensin (HNP-1) (Na-
gaoka et al, 2000). One microgram of LL-37 per ml (about 0.1 mM)
with 10 mg HNP-1 per ml kills 50% of E. coli and 60% of
S. aureus in 10 mM phosphate bu¡er containing 150 mM NaCl. In
our own experiments, 4 mM LL-37 increases the potency of hBD2
against S. aureus 4-fold (Ong et al, 2002).
Further study of the combined activities and regulation of skin
and sweat anti-microbial peptides will greatly advance our under-
standing of this system of skin defense. An association between a
lack of development of eccrine glands and decreased immune de-
fense has been described (Do⁄nger et al, 2001; Jain et al, 2001). In
these patients the immune defect results not from a primary de-
fect in sweat but from a common dependency on nuclear factor-
kB signaling mechanisms in eccrine development and immune
response. This intriguing association between development of
the eccrine apparatus and the immune system supports a hypoth-
esis that during evolution the immune defense role of the eccrine
appendage was greater than at present. Now, human keratino-
cytes can rapidly respond to injury by production of anti-micro-
bial peptides, and neutrophils are recruited as a means of delivery
of natural antibiotics. These additional innate immune systems
diminish dependence on sweat as a defense barrier. Furthermore,
it has become clear that several unique systems of gene regu-
lation and protein processing contribute to the function of anti-
microbial peptides in di¡erent tissues. Thus, current information
regarding anti-microbial e¡ector molecules, combined with
advancing understanding of the control of innate immunity, sug-
gests these molecules are likely to play an important part in host
defense and may provide important diagnostic and therapeutic
advances towards the treatment of disease.
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